T. Rowe Price Associates’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-304,577
| Closed | -$12.8M | – | 2571 |
|
|
2017
Q4 | $12.8M | Buy |
304,577
+58,147
| +24% | +$2.45M | ﹤0.01% | 1281 |
|
|
2017
Q3 | $13.6M | Sell |
246,430
-113,557
| -32% | -$6.25M | ﹤0.01% | 1271 |
|
|
2017
Q2 | $66.8M | Buy |
359,987
+84,903
| +31% | +$15.8M | 0.01% | 734 |
|
|
2017
Q1 | $32.9M | Sell |
275,084
-155,300
| -36% | -$18.6M | 0.01% | 960 |
|
|
2016
Q4 | $42.8M | Buy |
430,384
+33,150
| +8% | +$3.29M | 0.01% | 865 |
|
|
2016
Q3 | $44.5M | Buy |
397,234
+130,347
| +49% | +$14.6M | 0.01% | 850 |
|
|
2016
Q2 | $27.4M | Buy |
266,887
+97,141
| +57% | +$9.98M | 0.01% | 993 |
|
|
2016
Q1 | $15.6M | Buy |
169,746
+43,471
| +34% | +$3.99M | ﹤0.01% | 1160 |
|
|
2015
Q4 | $18.2M | Buy |
126,275
+2,467
| +2% | +$356K | ﹤0.01% | 1112 |
|
|
2015
Q3 | $12.8M | Sell |
123,808
-1,192
| -1% | -$123K | ﹤0.01% | 1244 |
|
|
2015
Q2 | $20.4M | Buy |
+125,000
| New | +$20.4M | ﹤0.01% | 1130 |
|